These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 16950832

  • 1. The role of the nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitis.
    Yamazaki Y, Kakizaki S, Horiguchi N, Sohara N, Sato K, Takagi H, Mori M, Negishi M.
    Gut; 2007 Apr; 56(4):565-74. PubMed ID: 16950832
    [Abstract] [Full Text] [Related]

  • 2. Interstrain differences in susceptibility to non-alcoholic steatohepatitis.
    Yamazaki Y, Kakizaki S, Takizawa D, Ichikawa T, Sato K, Takagi H, Mori M.
    J Gastroenterol Hepatol; 2008 Feb; 23(2):276-82. PubMed ID: 17868334
    [Abstract] [Full Text] [Related]

  • 3. Constitutive active/androstane receptor promotes hepatocarcinogenesis in a mouse model of non-alcoholic steatohepatitis.
    Takizawa D, Kakizaki S, Horiguchi N, Yamazaki Y, Tojima H, Mori M.
    Carcinogenesis; 2011 Apr; 32(4):576-83. PubMed ID: 21173431
    [Abstract] [Full Text] [Related]

  • 4. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.
    Sahai A, Malladi P, Melin-Aldana H, Green RM, Whitington PF.
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G264-73. PubMed ID: 15044174
    [Abstract] [Full Text] [Related]

  • 5. Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency.
    Kirsch R, Clarkson V, Verdonk RC, Marais AD, Shephard EG, Ryffel B, de la M Hall P.
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):174-82. PubMed ID: 16706830
    [Abstract] [Full Text] [Related]

  • 6. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet.
    Koppe SW, Sahai A, Malladi P, Whitington PF, Green RM.
    J Hepatol; 2004 Oct; 41(4):592-8. PubMed ID: 15464239
    [Abstract] [Full Text] [Related]

  • 7. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
    Farrell GC, Larter CZ, Hou JY, Zhang RH, Yeh MM, Williams J, dela Pena A, Francisco R, Osvath SR, Brooling J, Teoh N, Sedger LM.
    J Gastroenterol Hepatol; 2009 Mar; 24(3):443-52. PubMed ID: 19226377
    [Abstract] [Full Text] [Related]

  • 8. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
    Nocito A, Dahm F, Jochum W, Jang JH, Georgiev P, Bader M, Renner EL, Clavien PA.
    Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
    [Abstract] [Full Text] [Related]

  • 9. Effects of iron overload in a rat nutritional model of non-alcoholic fatty liver disease.
    Kirsch R, Sijtsema HP, Tlali M, Marais AD, Hall Pde L.
    Liver Int; 2006 Dec; 26(10):1258-67. PubMed ID: 17105592
    [Abstract] [Full Text] [Related]

  • 10. Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis.
    Zhang S, Wang J, Liu Q, Harnish DC.
    J Hepatol; 2009 Aug; 51(2):380-8. PubMed ID: 19501927
    [Abstract] [Full Text] [Related]

  • 11. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice.
    McCuskey RS, Ito Y, Robertson GR, McCuskey MK, Perry M, Farrell GC.
    Hepatology; 2004 Aug; 40(2):386-93. PubMed ID: 15368443
    [Abstract] [Full Text] [Related]

  • 12. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
    Larter CZ, Yeh MM, Cheng J, Williams J, Brown S, dela Pena A, Bell-Anderson KS, Farrell GC.
    J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
    [Abstract] [Full Text] [Related]

  • 13. Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis.
    Sugino H, Kumagai N, Watanabe S, Toda K, Takeuchi O, Tsunematsu S, Morinaga S, Tsuchimoto K.
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1909-16. PubMed ID: 18422963
    [Abstract] [Full Text] [Related]

  • 14. Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice.
    Min AK, Kim MK, Kim HS, Seo HY, Lee KU, Kim JG, Park KG, Lee IK.
    Life Sci; 2012 Jan 30; 90(5-6):200-5. PubMed ID: 22154902
    [Abstract] [Full Text] [Related]

  • 15. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP, Stone WC, Karaca FG, Syn WK, Pereira TA, Agboola KM, Omenetti A, Jung Y, Teaberry V, Choi SS, Guy CD, Pollard J, Charlton P, Diehl AM.
    Hepatology; 2009 Nov 30; 50(5):1421-30. PubMed ID: 19676126
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes.
    Larter CZ, Yeh MM, Williams J, Bell-Anderson KS, Farrell GC.
    J Hepatol; 2008 Sep 30; 49(3):407-16. PubMed ID: 18534710
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.